Royal Philips Electronics

University College Dublin of Dublin, Ireland, has received US Patent No. 8,116,551, "Method and system for image analysis." A method for determining the level of expression of objects of interest using an automated image analysis system is claimed.

In addition, Argene will provide BioMérieux with a portfolio of molecular tests for diagnosing infectious diseases in transplant and other immunocompromised patients.

The deal marks the latest move by RXi to expand its access to new delivery approaches, and may offer some clues as to the therapeutic course RXi is setting for itself, which it will disclose at an investor conference this week.

The Swiss firm said that it will use the cash to accelerate development and validation of the first version of its forthcoming molecular diagnostics platform, which will incorporate nucleic acid sample prep technology recently acquired from Royal Philips Electronics.

The platform features new nucleic acid sample prep and amplification technologies and will be developed for a wide range of DNA and RNA molecular diagnostic testing, including in oncology and infectious diseases, according to a Biocartis executive.

Biocartis has formed a Dutch subsidiary that will collaborate with Philips on further developing the molecular diagnostics platform.

The firms are working on a molecular imaging platform that combines their respective expertise and technologies.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.